These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 31889549)

  • 1. Intravenous leiomyomatosis: molecular analysis of 17 cases.
    Lu B; Liu Q; Tang L; Ma Y; Shi H
    Pathology; 2020 Feb; 52(2):213-217. PubMed ID: 31889549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MED12 exon 2 mutation is uncommon in intravenous leiomyomatosis: clinicopathologic features and molecular study.
    Wang L; Hu S; Xin F; Zhao H; Li G; Ran W; Xing X; Wang J
    Hum Pathol; 2020 May; 99():36-42. PubMed ID: 32240666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A clinicopathological and molecular analysis in uterine leiomyomas and concurrent/metachronous peritoneal nodules: New insights into disseminated peritoneal leiomyomatosis.
    Ma Y; Wang S; Liu Q; Lu B
    Pathol Res Pract; 2020 May; 216(5):152938. PubMed ID: 32234244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MED12 and HMGA2 mutations: two independent genetic events in uterine leiomyoma and leiomyosarcoma.
    Bertsch E; Qiang W; Zhang Q; Espona-Fiedler M; Druschitz S; Liu Y; Mittal K; Kong B; Kurita T; Wei JJ
    Mod Pathol; 2014 Aug; 27(8):1144-53. PubMed ID: 24390224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MED12 exon 2 mutations in uterine and extrauterine smooth muscle tumors.
    Schwetye KE; Pfeifer JD; Duncavage EJ
    Hum Pathol; 2014 Jan; 45(1):65-70. PubMed ID: 24196187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous leiomyomatosis of the uterus: A clinicopathologic analysis of 13 cases with an emphasis on histogenesis.
    Tang L; Lu B
    Pathol Res Pract; 2018 Jun; 214(6):871-875. PubMed ID: 29699902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MED12 exon 2 mutations in histopathological uterine leiomyoma variants.
    Mäkinen N; Vahteristo P; Kämpjärvi K; Arola J; Bützow R; Aaltonen LA
    Eur J Hum Genet; 2013 Nov; 21(11):1300-3. PubMed ID: 23443020
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous leiomyomatosis: an unusual intermediate between benign and malignant uterine smooth muscle tumors.
    Ordulu Z; Nucci MR; Dal Cin P; Hollowell ML; Otis CN; Hornick JL; Park PJ; Kim TM; Quade BJ; Morton CC
    Mod Pathol; 2016 May; 29(5):500-10. PubMed ID: 26892441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intravenous leiomyomatosis is inclined to a solid entity different from uterine leiomyoma based on RNA-seq analysis with RT-qPCR validation.
    Wang W; Wang Y; Chen F; Zhang M; Jia R; Liu X; Zhang C; Shao J; Cheng N; Ma G; Zhu Z; Miao Q; Liang Z
    Cancer Med; 2020 Jul; 9(13):4581-4592. PubMed ID: 32372565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent chromosomal aberrations in intravenous leiomyomatosis of the uterus: high-resolution array comparative genomic hybridization study.
    Buza N; Xu F; Wu W; Carr RJ; Li P; Hui P
    Hum Pathol; 2014 Sep; 45(9):1885-92. PubMed ID: 25033729
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of MED12 mutations in uterine and extrauterine smooth muscle tumours.
    Matsubara A; Sekine S; Yoshida M; Yoshida A; Taniguchi H; Kushima R; Tsuda H; Kanai Y
    Histopathology; 2013 Mar; 62(4):657-61. PubMed ID: 23347103
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation status of the mediator complex subunit 12 (MED12) in uterine leiomyomas and concurrent/metachronous multifocal peritoneal smooth muscle nodules (leiomyomatosis peritonealis disseminata).
    Rieker RJ; Agaimy A; Moskalev EA; Hebele S; Hein A; Mehlhorn G; Beckmann MW; Hartmann A; Haller F
    Pathology; 2013 Jun; 45(4):388-92. PubMed ID: 23635816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic molecular and clinical analysis of uterine leiomyomas from fertile-aged women undergoing myomectomy.
    Äyräväinen A; Pasanen A; Ahvenainen T; Heikkinen T; Pakarinen P; Härkki P; Vahteristo P
    Hum Reprod; 2020 Oct; 35(10):2237-2244. PubMed ID: 32829387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of
    Lee M; Cheon K; Chae B; Hwang H; Kim HK; Chung YJ; Song JY; Cho HH; Kim JH; Kim MR
    Int J Med Sci; 2018; 15(2):124-128. PubMed ID: 29333096
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of MED12, HMGA2, and FH alterations reveals molecular variability in uterine smooth muscle tumors.
    Mäkinen N; Kämpjärvi K; Frizzell N; Bützow R; Vahteristo P
    Mol Cancer; 2017 Jun; 16(1):101. PubMed ID: 28592321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous leiomyomatosis is characterized by a der(14)t(12;14)(q15;q24).
    Dal Cin P; Quade BJ; Neskey DM; Kleinman MS; Weremowicz S; Morton CC
    Genes Chromosomes Cancer; 2003 Feb; 36(2):205-6. PubMed ID: 12508249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HMGA2 and MED12 alterations frequently co-occur in uterine leiomyomas.
    Galindo LJ; Hernández-Beeftink T; Salas A; Jung Y; Reyes R; de Oca FM; Hernández M; Almeida TA
    Gynecol Oncol; 2018 Sep; 150(3):562-568. PubMed ID: 30017537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple clinical characteristics separate MED12-mutation-positive and -negative uterine leiomyomas.
    Heinonen HR; Pasanen A; Heikinheimo O; Tanskanen T; Palin K; Tolvanen J; Vahteristo P; Sjöberg J; Pitkänen E; Bützow R; Mäkinen N; Aaltonen LA
    Sci Rep; 2017 Apr; 7(1):1015. PubMed ID: 28432313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation.
    Corachán A; Trejo MG; Carbajo-García MC; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
    Fertil Steril; 2021 Feb; 115(2):512-521. PubMed ID: 33036796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.
    Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA
    Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.